ARKG Holdings of Schrödinger, Inc. (SDGR) - Updated Daily
Software As A ServiceBioinformaticsGenomics
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 4.46% | $2.64b |
| 🏋🏿♂️Weight Rank In ARKG | 🌏Country |
| 5 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 33 | $57.16 |
| 🎫ARK Ownership Percent | |
| 4.48% | |
| Description | |
|---|---|
| schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. the predictive power of schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries that might otherwise not be possible. schrödinger also establishes deep partnerships and collaborations with companies in such fields as biotechnology, pharmaceuticals, chemicals, and electronics, and helped found the biotech company nimbus therapeutics. through significant long-term investments in basic research, schrödinger has made scientific breakthroughs across many areas of drug discovery and materials science. hundreds of peer-reviewed scientific publications by schrödinger scientists are frequently among the most heavily cited in their fields. founded in 1990, schrödinger has operations in the us, europe, japan, and india, with business part | |
| Website | |
| https://www.schrodinger.com |
Other ETFs That Hold SDGR
Research Notes and Commentary for SDGR
No Research Notes Found for SDGR